Cost-effectiveness of screening and treatment using direct-acting antivirals for chronic hepatitis C virus in low- and middle-income settings
Josephine Walker,Nyashadzaishe Mafirakureva,Lara Marquez,Jack Stone,Aaron G. Lim,Linda Campbell,Gul Ghuttai Khalid,Momoko Iwamoto,Khawar Aslam,Yves Wailly,Hassaan Zahid,Dmytro Donchuk,Camille Fortas,Gregoire Falq, Kyi Piar Soe,Antoine Chaillon,Vincent Lo Re Iii,Adriane Wynn,Craig McIntosh, Derek Johnson,Jean-Marc Zosso,Aude Nguyen,Susan Kiene,Stephanie Brodine,Richard Garfein, Reuben Hastings, San Kimchamroeun,Mickael Le Paih,Jean-Philippe Dousset,Suna Balkan,Tonia Marquardt,Esther Mucara, C. Ines Gonzalez,Walter Kizito,Yvonne Nzomukunda,Peter Cherutich,Charles Cleland,John Lizcano,Nok Chhun,Ann Kurth,Helgar Musyoki,Parinita Bhattacharjee,Wanjiru Waruiru,Ben Mundia,David Maman,Niklas Luhmann,Joanna Coast,Anne Loarec,Natasha Martin,Peter Vickerman Journal of Hepatology(2020)
关键词
cost-effectiveness cost-effectiveness,antivirals,direct-acting,middle-income
AI 理解论文
溯源树
样例